ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1166

Scleroderma Fibroblasts Induce Alternative Macrophage Activation via an ERK1/2-dependent Mechanism

Taha Dinc1, Juan-Pablo Zertuche1, Fatima El Adili2, Maria Trojanowska3 and Andreea Bujor3, 1Boston University School of Medicine, Boston, MA, 2Boston University School of Medicine, Revere, MA, 3Boston University, Boston, MA

Meeting: ACR Convergence 2022

Keywords: immunology, macrophages, Scleroderma

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Systemic Sclerosis and Related Disorders – Basic Science Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Activation of the innate immune system in systemic sclerosis (SSc), with an increased number of profibrotic/alternatively-activated macrophages in affected tissues, is an important aspect of disease pathogenesis. The exact mechanisms governing profibrotic macrophage activation and the potential crosstalk between resident fibroblasts and infiltrating macrophages have not been elucidated. MAPK/ERK1/2 signaling has been linked to inflammation and remodeling, but its role in alternative macrophage activation in SSc has not been explored.

Methods: Microarray analysis was performed using the Affymetrix GeneChip™human 2.0 ST gene array on macrophages stimulated with conditioned media from healthy control (HC) or SSc fibroblasts. Ingenuity Pathway Analysis (IPA) was carried out to see differentially regulated canonical pathways. THP1 cells were plated in direct co-culture with equal numbers of SSc or HC dermal fibroblasts. To inhibit signaling via ERK1/2, 5 µM of the SCH772984 specific ERK1/2 inhibitor was used. Activation of the ERK1/2 pathway was checked using pERk1/2 (Thr202/Tyr204, Cell Signaling) specific antibodies via Western blot. Quantitative real-time PCR was used to assess mRNA levels of profibrotic macrophage markers CD163 and CD204, with GAPDH as internal control.

Results: IPA analysis of human macrophages showed upregulated ERK/MAPK signaling pathway (p 0.0003). Western blot analyses of extracts from THP1 cocultured with SSc or HC fibroblasts showed higher levels of phosphorylated ERK1/2 in SSc vs HC fibroblast stimulated THP1 cells (Figure 1). Coculture of THP1 cells with fibroblasts induced increased expression of the alternatively-activated macrophage markers CD163 and CD204, with a more potent upregulation seen in response to SSc fibroblasts compared HC fibroblasts (9.5x vs 4.5x respectively compared to baseline, Figure 2). The effects on CD163 but not CD204 were abrogated by pretreatment with the ERK1/2 inhibitor.

Conclusion: In this study, we show that SSc fibroblasts induce increased CD163 expression in macrophages via an ERK1/2 dependent pathway, suggesting that crosstalk between fibroblasts and tissue resident macrophages may contribute to the alternative macrophage activation see in SSc.

Supporting image 1

Figure 1. Western blot analysis of cell extracts from THP1 cells in coculture with NS (normal, healthy control) and SSc dermal fibroblasts showing increased phosphorylation of ERK1/2.

Supporting image 2

Figure 2. Increased CD163 mRNA levels in TJP1 cocultured with SSc and control fibroblasts. One way Anova (P<0.0001), followed by Tukey’s multiple comparisons test was used for the analysis.


Disclosures: T. Dinc, None; J. Zertuche, None; F. El Adili, None; M. Trojanowska, None; A. Bujor, None.

To cite this abstract in AMA style:

Dinc T, Zertuche J, El Adili F, Trojanowska M, Bujor A. Scleroderma Fibroblasts Induce Alternative Macrophage Activation via an ERK1/2-dependent Mechanism [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/scleroderma-fibroblasts-induce-alternative-macrophage-activation-via-an-erk1-2-dependent-mechanism/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/scleroderma-fibroblasts-induce-alternative-macrophage-activation-via-an-erk1-2-dependent-mechanism/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology